Trial Details

TERMINATED
Basic Information
Clinical ID c1587
Identifier NCT04839315
Trial Title COVID-19 Vaccination in Rheumatic Disease Patients
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Systemic Lupus Erythematosus|Sjogren's Syndrome|Inflammatory Myositis|Psoriatic Arthritis|Gout|Ankylosing Spondylitis|Arthritis of Multiple Sites Associated With Inflammatory Bowel Disease (Diagnosis)|Osteoarthritis
Interventions BIOLOGICAL: mRNA COVD19 vaccine
Participant Information
Sponsor Mayo Clinic
City Rochester
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase EARLY_PHASE1
Time Information
Start Date 2021-02-15
Primary Completion Date 2022-02-09
Completion Date 2022-02-09